{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T15:39:44Z","timestamp":1790177984117,"version":"4.1.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2014,3,18]],"date-time":"2014-03-18T00:00:00Z","timestamp":1395100800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1007\/s00296-014-2984-4","type":"journal-article","created":{"date-parts":[[2014,3,18]],"date-time":"2014-03-18T05:38:49Z","timestamp":1395121129000},"page":"1319-1322","source":"Crossref","is-referenced-by-count":16,"title":["Dermatomyositis as a complication of interferon-\u03b1 therapy: a case report and review of the literature"],"prefix":"10.1007","volume":"34","author":[{"given":"Hideyuki","family":"Shiba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tohru","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Isoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhito","family":"Kokunai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumiko","family":"Wada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeki","family":"Makino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Hanafusa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,3,18]]},"reference":[{"key":"2984_CR1","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s11926-011-0166-x","volume":"13","author":"L Kao","year":"2011","unstructured":"Kao L, Chung L, Fiorentino DF (2011) Pathogenesis of dermatomyositis: role of cytokines and interferon. Curr Rheumatol Rep 13:225\u2013232","journal-title":"Curr Rheumatol Rep"},{"key":"2984_CR2","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1212\/01.WNL.0000151856.10387.E2","volume":"64","author":"T Saida","year":"2005","unstructured":"Saida T, Tashiro K, Itoyama Y et al (2005) Interferon Beta-1b multiple sclerosis study group of Japan. Interferon beta-1b is effective in Japanese RRMS patients: a randomized, multicenter study. Neurology 64:621\u2013630","journal-title":"Neurology"},{"key":"2984_CR3","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292:344\u2013347","journal-title":"N Engl J Med"},{"key":"2984_CR4","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM197502202920807","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (second of two parts). N Engl J Med 292:403\u2013407","journal-title":"N Engl J Med"},{"key":"2984_CR5","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jbspin.2010.07.012","volume":"78","author":"A Aouba","year":"2011","unstructured":"Aouba A, Georgin-Lavialle S, Terrier B et al (2011) Anti-PL7 antisynthetase syndrome under interferon therapy. Joint Bone Spine 78:94\u201397","journal-title":"Joint Bone Spine"},{"key":"2984_CR6","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/BF02826219","volume":"17","author":"LL Dietrich","year":"2000","unstructured":"Dietrich LL, Bridges AJ, Albertini MR (2000) Dermatomyositis after interferon alpha treatment. Med Oncol 17:64\u201369","journal-title":"Med Oncol"},{"key":"2984_CR7","first-page":"147","volume":"26","author":"A John","year":"2007","unstructured":"John A, El Emadi S, Al Kaabi S et al (2007) Polymyositis during pegylated alpha-interferon ribavirin therapy for chronic hepatitis. Indian J Gastroenterol 26:147\u2013148","journal-title":"Indian J Gastroenterol"},{"key":"2984_CR8","doi-asserted-by":"crossref","first-page":"806","DOI":"10.2169\/internalmedicine.33.806","volume":"33","author":"M Matsuya","year":"1994","unstructured":"Matsuya M, Abe T, Tosaka M et al (1994) The first case of polymyositis associated with interferon therapy. Intern Med 33:806\u2013808","journal-title":"Intern Med"},{"key":"2984_CR9","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/art.1780390634","volume":"39","author":"C Ferri","year":"1996","unstructured":"Ferri C, La Civita L, Fazzi P et al (1996) Polymyositis, lung fibrosis, and cranial neuropathy in a patient with hepatitis C virus infection. Arthritis Rheum 39:1074\u20131075","journal-title":"Arthritis Rheum"},{"key":"2984_CR10","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.dld.2005.06.010","volume":"37","author":"G Venezia","year":"2005","unstructured":"Venezia G, Licata A, Di Marco V et al (2005) Acute polymyositis during treatment of acute hepatitis C with pegylated interferon alpha-2b. Dig Liver Dis 37:882\u2013885","journal-title":"Dig Liver Dis"},{"key":"2984_CR11","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3346\/jkms.2002.17.1.141","volume":"17","author":"SW Lee","year":"2002","unstructured":"Lee SW, Kim KC, Oh DH et al (2002) A case of polymyositis with dilated cardiomyopathy associated with interferon alpha treatment for hepatitis B. J Korean Med Sci 17:141\u2013143","journal-title":"J Korean Med Sci"},{"key":"2984_CR12","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1212\/WNL.54.11.2186","volume":"54","author":"GJ Hengstman","year":"2000","unstructured":"Hengstman GJ, Vogels OJ, ter Laak HJ et al (2000) Myositis during long-term interferon-alpha treatment. Neurology 54:2186","journal-title":"Neurology"},{"key":"2984_CR13","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s002960050103","volume":"19","author":"G Cirigliano","year":"1999","unstructured":"Cirigliano G, Della Rossa A, Tavoni A et al (1999) Polymyositis occurring during alpha-interferon treatment for malignant melanoma: a case report and review of the literature. Rheumatol Int 19:65\u201367","journal-title":"Rheumatol Int"},{"key":"2984_CR14","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/sj.leu.2401104","volume":"12","author":"A Falcone","year":"1998","unstructured":"Falcone A, Bodenizza CA, Musto P et al (1998) Symptomatic myopathy during interferon alpha therapy for chronic myelogenous leukemia. Leukemia 12:1329","journal-title":"Leukemia"},{"key":"2984_CR15","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1177\/0961203308093550","volume":"18","author":"B Bonaci-Nikolic","year":"2009","unstructured":"Bonaci-Nikolic B, Jeremic I, Andrejevic S et al (2009) Anti-double stranded DNA and lupus syndrome induced by interferon-beta therapy in a patient with multiple sclerosis. Lupus 18:78\u201380","journal-title":"Lupus"},{"key":"2984_CR16","first-page":"4","volume":"32","author":"V Sladkova","year":"2011","unstructured":"Sladkova V, Mares J, Lubenova B et al (2011) Drug-induced systemic lupus erythematosus in interferon beta-1b therapy. Neuro Endocrinol Lett 32:4\u20136","journal-title":"Neuro Endocrinol Lett"},{"key":"2984_CR17","first-page":"609","volume":"44","author":"Y Warabi","year":"2004","unstructured":"Warabi Y, Matsubara S, Mizutani T et al (2004) Inclusion body myositis after interferon-alpha treatment in a patient with HCV and HTLV-1 infection. Rinsho Shinkeigaku 44:609\u2013614 [in Japanese]","journal-title":"Rinsho Shinkeigaku"},{"key":"2984_CR18","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1111\/j.1600-6143.2009.02702.x","volume":"9","author":"K Watt","year":"2009","unstructured":"Watt K, Veldt B, Charlton M (2009) A practical guide to the management of HCV infection following liver transplantation. Am J Transplant 9:1707\u20131713","journal-title":"Am J Transplant"},{"key":"2984_CR19","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/sj.gene.6364409","volume":"8","author":"C Kyogoku","year":"2007","unstructured":"Kyogoku C, Tsuchiya N (2007) A compass that points to lupus: genetic studies on type I interferon pathway. Genes Immun 8:445\u2013455","journal-title":"Genes Immun"},{"key":"2984_CR20","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/j.1365-2230.2006.02150.x","volume":"31","author":"J Wenzel","year":"2006","unstructured":"Wenzel J, Schmidt R, Proelss J (2006) Type I interferon-associated skin recruitment of CXCR3+ lymphocytes in dermatomyositis. Clin Exp Dermatol 31:576\u2013582","journal-title":"Clin Exp Dermatol"},{"key":"2984_CR21","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1212\/01.WNL.0000291619.17160.b8","volume":"69","author":"SA Greenberg","year":"2007","unstructured":"Greenberg SA (2007) Proposed immunologic models of the inflammatory myopathies and potential therapeutic implications. Neurology 69:2008\u20132019","journal-title":"Neurology"},{"key":"2984_CR22","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/ana.20464","volume":"57","author":"SA Greenberg","year":"2005","unstructured":"Greenberg SA, Pinkus JL, Pinkus GS et al (2005) Interferon-alpha\/beta-mediated innate immune mechanisms in dermatomyositis. Ann Neurol 57:664\u2013678","journal-title":"Ann Neurol"},{"key":"2984_CR23","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2119\/2006-00085.Baechler","volume":"13","author":"EC Baechler","year":"2007","unstructured":"Baechler EC, Bauer JW, Slattery CA et al (2007) An interferon signature in the peripheral blood of dermatomyositis patients is associated with disease activity. Mol Med 13:59\u201368","journal-title":"Mol Med"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-014-2984-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-014-2984-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-014-2984-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T19:13:37Z","timestamp":1551208417000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-014-2984-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,18]]},"references-count":23,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["2984"],"URL":"https:\/\/doi.org\/10.1007\/s00296-014-2984-4","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,18]]}}}